{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:12:08Z","timestamp":1778685128170,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["10912041004"],"award-info":[{"award-number":["10912041004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2113-M-003-021"],"award-info":[{"award-number":["110-2113-M-003-021"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biochi.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T02:16:30Z","timestamp":1646014590000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity"],"prefix":"10.1016","volume":"197","author":[{"given":"I-Ching","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ping","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Ju","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-3978","authenticated-orcid":false,"given":"Ling-Hsien","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2022.02.007_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.sbi.2008.10.001","article-title":"Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases","volume":"18","author":"Bellotti","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.biochi.2022.02.007_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10408369209105246","article-title":"A\u00a0critical analysis of postulated pathogenetic mechanisms in amyloidogenesis","volume":"29","author":"Kisilevsky","year":"1992","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.biochi.2022.02.007_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biochi.2022.02.007_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2022.02.007_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biochi.2022.02.007_bib6","first-page":"2798269","article-title":"Islet amyloid polypeptide: structure, function, and pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.biochi.2022.02.007_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A\u00a0new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2022.02.007_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00198-007-0490-1","article-title":"Salmon calcitonin: a review of current and future therapeutic indications","volume":"19","author":"Chesnut","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biochi.2022.02.007_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/art.1780231011","article-title":"Chemistry, physiology, and therapeutic applications of calcitonin","volume":"23","author":"MacIntyre","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biochi.2022.02.007_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S8756-3282(99)00200-8","article-title":"Effects of calcitonin on animal and in\u00a0vitro models of skeletal metabolism","volume":"25","author":"Wallach","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.biochi.2022.02.007_bib11","first-page":"491","article-title":"Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis","volume":"35","author":"Robin","year":"1982","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.biochi.2022.02.007_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0021-5198(19)52589-6","article-title":"Calcitonin-induced anorexia in rats: a structure-activity study by intraventricular injections","volume":"32","author":"Yamamoto","year":"1982","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.biochi.2022.02.007_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1097-0142(197302)31:2<433::AID-CNCR2820310221>3.0.CO;2-F","article-title":"Medullary carcinoma of thyroid gland. Subcellular distribution of calcitonin and relationship between granules and amyloid","volume":"31","author":"Meyer","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.biochi.2022.02.007_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1110\/ps.9.5.867","article-title":"Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR","volume":"9","author":"Kamihira","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.biochi.2022.02.007_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mrc.1323","article-title":"Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy","volume":"42","author":"Naito","year":"2004","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.biochi.2022.02.007_bib16","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1039\/c3cp44544e","article-title":"Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation","volume":"15","author":"Itoh-Watanabe","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.biochi.2022.02.007_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fj.01-0442hyp","article-title":"A\u00a0possible role for pi-stacking in the self-assembly of amyloid fibrils","volume":"16","author":"Gazit","year":"2002","journal-title":"Faseb. J."},{"key":"10.1016\/j.biochi.2022.02.007_bib18","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1016\/S0021-9258(18)53267-1","article-title":"Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants","volume":"268","author":"Arvinte","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2022.02.007_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bip.360310210","article-title":"Solution structure of salmon calcitonin","volume":"31","author":"Meyer","year":"1991","journal-title":"Biopolymers"},{"key":"10.1016\/j.biochi.2022.02.007_bib20","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1073\/pnas.0501215102","article-title":"Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin","volume":"102","author":"Fowler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2022.02.007_bib21","doi-asserted-by":"crossref","first-page":"24193","DOI":"10.1074\/jbc.M603528200","article-title":"Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix","volume":"281","author":"Andreotti","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2022.02.007_bib22","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1074\/jbc.M110.182014","article-title":"Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue","volume":"286","author":"Andreotti","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2022.02.007_bib23","doi-asserted-by":"crossref","first-page":"10171","DOI":"10.1021\/acs.jpcb.9b08514","article-title":"Inhibiting human calcitonin fibril formation with its most relevant aggregation-resistant analog","volume":"123","author":"Chen","year":"2019","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.biochi.2022.02.007_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.niox.2020.08.002","article-title":"Y12 nitration of human calcitonin (hCT): a promising strategy to produce non-aggregation bioactive hCT","volume":"104\u2013105","author":"Ye","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biochi.2022.02.007_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bpj.2020.11.009","article-title":"Fibrillation of human calcitonin and its analogs: effects of phosphorylation and disulfide reduction","volume":"120","author":"Renawala","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.biochi.2022.02.007_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biochi.2020.08.012","article-title":"Role of lysine residue of islet amyloid polypeptide in fibril formation, membrane binding, and inhibitor binding","volume":"177","author":"Wu","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2022.02.007_bib27","doi-asserted-by":"crossref","first-page":"W315","DOI":"10.1093\/nar\/gky497","article-title":"BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra","volume":"46","author":"Micsonai","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2022.02.007_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1677\/joe.0.1300321","article-title":"Induction of calcitonin receptor expression by glucocorticoids in T47D human breast cancer cells","volume":"130","author":"Kurokawa","year":"1991","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.biochi.2022.02.007_bib29","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A\u00a0single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.biochi.2022.02.007_bib30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/acschemneuro.0c00069","article-title":"Acetylation of abeta42 at lysine 16 disrupts amyloid formation","volume":"11","author":"Adhikari","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2022.02.007_bib31","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1021\/acs.biochem.7b00209","article-title":"Role of site-specific asparagine deamidation in islet amyloid polypeptide amyloidogenesis: key contributions of residues 14 and 21","volume":"56","author":"Nguyen","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2022.02.007_bib32","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1021\/bi1002713","article-title":"Specific mutations alter fibrillation kinetics, fiber morphologies, and membrane interactions of pentapeptides derived from human calcitonin","volume":"49","author":"Shtainfeld","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2022.02.007_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nmeth0310-187","article-title":"Waltz, an exciting new move in amyloid prediction","volume":"7","author":"Oliveberg","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biochi.2022.02.007_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.sbi.2006.01.011","article-title":"Protein aggregation and amyloidosis: confusion of the kinds?","volume":"16","author":"Rousseau","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.biochi.2022.02.007_bib35","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.0915166107","article-title":"Identifying the amylome, proteins capable of forming amyloid-like fibrils","volume":"107","author":"Goldschmidt","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2022.02.007_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2017.1304905","article-title":"ThT 101: a primer on the use of thioflavin T to investigate amyloid formation","volume":"24","author":"Gade Malmos","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.biochi.2022.02.007_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12551-017-0353-8","article-title":"Recent progress on understanding the mechanisms of amyloid nucleation","volume":"10","author":"Chatani","year":"2018","journal-title":"Biophys Rev"},{"key":"10.1016\/j.biochi.2022.02.007_bib38","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1039\/C8CC02204F","article-title":"Secondary nucleation in amyloid formation","volume":"54","author":"Tornquist","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.biochi.2022.02.007_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1008365322148","article-title":"Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution","volume":"13","author":"Amodeo","year":"1999","journal-title":"J.\u00a0Biomol. NMR"},{"key":"10.1016\/j.biochi.2022.02.007_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/bip.20030","article-title":"The biological potency of a series of analogues of human calcitonin correlates with their interactions with phospholipids","volume":"76","author":"Epand","year":"2004","journal-title":"Biopolymers"},{"key":"10.1016\/j.biochi.2022.02.007_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jmb.2011.12.023","article-title":"NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG","volume":"416","author":"Huang","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2022.02.007_bib42","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1038\/srep13556","article-title":"Inhibitory effects of magnolol and honokiol on human calcitonin aggregation","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2022.02.007_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.actbio.2018.07.045","article-title":"Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity","volume":"78","author":"Shang","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biochi.2022.02.007_bib44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1021\/acs.chemrev.7b00568","article-title":"Biochemistry of peroxynitrite and protein tyrosine nitration","volume":"118","author":"Ferrer-Sueta","year":"2018","journal-title":"Chem. Rev."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908422000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908422000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:27:33Z","timestamp":1778682453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908422000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"alternative-id":["S0300908422000451"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2022.02.007","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}